<DOC>
	<DOC>NCT02152293</DOC>
	<brief_summary>The purpose of this study is to assess, in real life, the efficacy and the eligibility for discharge of a local anesthetic, CLOROTEKAL®, used for spinal anesthesia in short outpatient surgery.</brief_summary>
	<brief_title>Impact of Chloroprocaine (CLOROTEKAL®) on Eligibility for Discharge From Hospital After Outpatient Surgery</brief_title>
	<detailed_description>This is a longitudinal, observational, prospective, multicentre, national study, conducted in France, from a representative sample of physician anesthetists. The efficacy and safety in real life of CLOROTEKAL® will be assessed in patients undergoing a short outpatient surgery under spinal anesthesia. Data will be collected by the physician during two visits (pre-anesthesia and per-postoperative consultation). Additional data regarding the patient's perception (safety, pain and satisfaction) will be collected using a self-questionnaire.</detailed_description>
	<mesh_term>Chloroprocaine</mesh_term>
	<criteria>Adult patients seen in preanesthesia consultation for ambulatory surgery Patients for whom a spinal anesthesia using CLOROTEKAL® is planned Patients accepting and able to complete a satisfaction selfadministered questionnaire Informed patients who accept the computer processing of their medical data and their right of access and correction Patients with contraindications to spinal anesthesia (eg decompensated cardiac insufficiency, hypovolemic shock….) Patients with contraindications to chloroprocaine (hypersensitivity to the active substance, medicinal products of the paraaminobenzoic acid ester group, other estertype local anaesthetics or to any of the excipients ; Intravenous regional anaesthesia (the anesthetic agent is introduced into the limb and allowed to set in while tourniquets retain the agent within the desired area), serious problems with cardiac conduction, severe anemia) Patients participating or having participated in the previous month in a clinical trial in anesthesiology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>